Indexed with PubMed and Science Citation Index (E) 
Users online: 1328 
     Home | Feedback | Login 
About Current Issue Archive Ahead of print Search Instructions Online Submission Subscribe What's New Contact  
    Next article
    Previous article
    Table of Contents

    Similar in PUBMED
    Search Pubmed for
    Search in Google Scholar for
  Related articles
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded0    
    Comments [Add]    
    Cited by others 2    

Recommend this journal


Year : 2003  |  Volume : 69  |  Issue : 1  |  Page : 25--26

Treatment of schamberg's disease with pentoxifylline - therapeutic trial

Department of Dermatology and STD UCMS & GTB Hospital, Shahdara, Delhi - 110 095, India

Correspondence Address:
V Gandhi
Department of Dermatology and STD UCMS & GTB Hospital, Shahdara, Delhi - 110 095
Login to access the Email id

Source of Support: None, Conflict of Interest: None

PMID: 17642818

Rights and PermissionsRights and Permissions

Twenty patients with Schamberg's disease were started on pentoxifylline (400 mg once daily) for a period of 8 weeks. Improvement was assessed at 2 weekly intervals by two observers independently and graded as mild (<25%, moderate (25-50%) and marked (>50%). Marked improvement was observed in 10/20(50%) patients. We conclude that pentoxifylline should be considered as first line therapy in all patients with Schamberg's disease

[FULL TEXT] [PDF Not available]*

Print this article     Email this article

Online since 15th March '04
Published by Wolters Kluwer - Medknow